CRVS
CRVS
US2210151005
Corvus Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
42.971.000 27.548.000
56.0%
Operating Income -42.971.000 -27.548.000
56.0%
Pretax Income -15.283.000 -62.293.000
75.5%
Net Income Common Stockholders -15.283.000 -62.293.000
75.5%
-- --
--
-- --
--
ende